ClinConnect ClinConnect Logo
Search / Trial NCT00000450

Naltrexone Maintenance Treatment of Alcoholism

Launched by THE SCRIPPS RESEARCH INSTITUTE · Nov 2, 1999

Trial Information

Current as of May 09, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Meets criteria for alcohol dependence.
  • Expresses a desire to cut down or stop drinking.
  • Exclusion Criteria:
  • Currently meets criteria for dependence on substances other than alcohol.
  • History of opiate dependence or evidence of current opiate use.
  • Significant medical disorders that will increase potential risk or interfere with study participation.
  • Liver function tests more than 3 times normal or elevated bilirubin.
  • Female patients who are pregnant, nursing, or not using a reliable method of birth control.
  • Inability to understand and provide a consent form.
  • Treatment with an investigational drug during the previous month.
  • Prior treatment with naltrexone.
  • Chronic treatment with any narcotic-containing medications during the previous month.
  • Sensitivity to naltrexone as evidenced by adverse drug experiences especially with narcotic containing analgesics or opioid antagonists.
  • Current treatment with disulfiram.
  • More than 6 weeks of abstinence.
  • Meets criteria for a major psychiatric disorder and is in need of, or currently undergoing pharmacotherapy.

About The Scripps Research Institute

The Scripps Research Institute is a renowned non-profit biomedical research organization dedicated to advancing scientific knowledge and innovation in the life sciences. With a mission to enhance human health through groundbreaking research, Scripps Research conducts pioneering studies across various fields, including drug discovery, molecular biology, and immunology. The institute fosters a collaborative environment that integrates interdisciplinary approaches and state-of-the-art technologies, aiming to translate scientific discoveries into novel therapeutic interventions. Committed to excellence in research and education, Scripps Research plays a pivotal role in shaping the future of medicine and improving patient outcomes globally.

Locations

Miami, Florida, United States

Patients applied

0 patients applied

Trial Officials

Barbara Mason, Ph.D.

Principal Investigator

The Scripps Research Institute

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials